T
,Contents
Chapter i01: iThe iNursing iProcess iand iDrug iTherapy ............................................................................... 4
Chapter i02: iPharmacologic iPrinciples ..................................................................................................... 8
Chapter i03: iLifespan iConsiderations ..................................................................................................... 14
Chapter i04: iCultural, iLegal, iand iEthical iConsiderations ........................................................................ 20
Chapter i05: iMedication iErrors: iPreventing iand iResponding ................................................................. 26
Chapter i06: iPatient iEducation iand iDrug iTherapy.................................................................................. 29
Chapter i07: iOver-the-Counter iDrugs iand iHerbal iand iDietary iSupplements.......................................... 34
Chapter i08: iGene iTherapy iand iPharmacogenomics .............................................................................. 38
Chapter i09: iPhoto iAtlas iof iDrug iAdministration ................................................................................... 41
Chapter i10: iAnalgesic iDrugs.................................................................................................................. 50
Chapter i11: iGeneral iand iLocal iAnesthetics........................................................................................... 57
Chapter i12: iCentral iNervous iSystem iDepressants iand iMuscle iRelaxants.............................................. 61
Chapter i13: iCentral iNervous iSystem iStimulants iand iRelated iDrugs..................................................... 66
Chapter i14: iAntiepileptic iDrugs ............................................................................................................ 70
Chapter i15: iAntiparkinson iDrugs........................................................................................................... 76
Chapter i16: iPsychotherapeutic iDrugs ................................................................................................... 81
Chapter i17: iSubstance iUse iDisorder ..................................................................................................... 88
Chapter i18: iAdrenergic iDrugs ............................................................................................................... 93
Chapter i19: iAdrenergic-Blocking iDrugs ................................................................................................. 98
Chapter i20: iCholinergic iDrugs............................................................................................................. 103
Chapter i21: iCholinergic-Blocking iDrugs............................................................................................... 108
Chapter i22: iAntihypertensive iDrugs.................................................................................................... 113
Chapter i23: iAntianginal iDrugs ............................................................................................................ 119
Chapter i24: iHeart iFailure iDrugs .......................................................................................................... 125
Chapter i25: iAntidysrhythmic iDrugs .................................................................................................... 131
Chapter i26: iCoagulation iModifier iDrugs ............................................................................................. 137
Chapter i27: iAntilipemic iDrugs............................................................................................................. 143
Chapter i28: iDiuretic iDrugs .................................................................................................................. 148
Chapter i29: iFluids iand iElectrolytes ..................................................................................................... 154
Chapter i30: iPituitary iDrugs ................................................................................................................. 160
,Chapter i31: iThyroid iand iAntithyroid iDrugs......................................................................................... 163
Chapter i32: iAntidiabetic iDrugs ........................................................................................................... 168
Chapter i33: iAdrenal iDrugs .................................................................................................................. 177
Chapter i34: iWomen’s iHealth iDrugs .................................................................................................... 181
Chapter i35: iMen’s iHealth iDrugs ......................................................................................................... 188
Chapter i36: iAntihistamines, iDecongestants, iAntitussives, iand iExpectorants ...................................... 193
Chapter i37: iRespiratory iDrugs ............................................................................................................ 198
Chapter i38: iAntibiotics iPart i1 ............................................................................................................. 204
Chapter i39: iAntibiotics iPart i2 ............................................................................................................. 211
Chapter i40: iAntiviral iDrugs ................................................................................................................. 216
Chapter i41: iAntitubercular iDrugs ........................................................................................................ 221
Chapter i42: iAntifungal iDrugs .............................................................................................................. 226
Chapter i43: iAntimalarial, iAntiprotozoal, iand iAnthelmintic iDrugs ....................................................... 231
Chapter i44: iAnti-inflammatory iand iAntigout iDrugs ............................................................................ 236
Chapter i45: iAntineoplastic iDrugs iPart i1: iCancer iOverview iand iCell iCycle–Specific iDrugs .................. 242
Chapter i46: iAntineoplastic iDrugs iPart i2: iCell iCycle–Nonspecific iDrugs iand iMiscellaneous iDrugs....... 248
Chapter i47: iBiologic iResponse–Modifying iand iAntirheumatic iDrugs .................................................. 253
Chapter i48: iImmunosuppressant iDrugs .............................................................................................. 258
Chapter i49: iImmunizing iDrugs ............................................................................................................ 263
Chapter i50: iAcid-Controlling iDrugs ..................................................................................................... 268
Chapter i51: iBowel iDisorder iDrugs ...................................................................................................... 274
Chapter i52: iAntiemetic iand iAntinausea iDrugs ................................................................................... 281
Chapter i53: iVitamins iand iMinerals ..................................................................................................... 286
Chapter i54: iAnemia iDrugs .................................................................................................................. 292
Chapter i55: iNutritional iSupplements .................................................................................................. 299
Chapter i56: iDermatologic iDrugs ......................................................................................................... 304
Chapter i57: iOphthalmic iDrugs ............................................................................................................ 310
Chapter i58: iOtic iDrugs ........................................................................................................................ 315
, Chapter i01: iThe iNursing iProcess iand iDrug iTherapy i i i i i 4
Chapter 01: The Nursing Process and Drug Therapy
i i i i i i i
MULTIPLE iCHOICE
1. The inurse iis iwriting ia inursing idiagnosis ifor ia iplan iof icare ifor ia ipatient iwho ihas ibeen
newlyidiagnosed iwith itype i2 idiabetes. iWhich istatement ireflects ithe icorrect iformat ifor ia
i
nursing idiagnosis?
i
a. Anxiety
b. Anxiety irelated ito inew idrug itherapy
c. Anxiety irelated ito ianxious ifeelings iabout idrug itherapy, ias ievidenced iby
istatementsisuch ias i―I‘m iupset iabout i having ito itest imy iblood i sugars.‖
d. Anxiety irelated ito inew idrug itherapy, ias ievidenced iby istatements isuch ias
i ―I‘m iupset iabout ihaving ito itest i my iblood i sugars.‖
ANS: i D
Formulation iof inursing idiagnoses iis iusually ia ithree-step iprocess. i―Anxiety‖ iis imissing ithe
―related ito‖ iand i―as ievidenced iby‖ iportions iof idefining icharacteristics. i―Anxiety irelated ito
inew idrug itherapy‖ iis imissing ithe i―as ievidenced iby‖ iportion iof idefining icharacteristics. iThe
istatementibeginning i―Anxiety irelated ito ianxious ifeelings‖ iis iincorrect ibecause ithe i ―related ito‖
isection iis i simply ia irestatement iof ithe iproblem i ―anxiety,‖ inot ia iseparate ifactor irelated ito ithe
iresponse.
DIF: COGNITIVE iLEVEL: iUnderstanding
i(Comprehension)iTOP: i NURSING iPROCESS: iNursing
iDiagnosis
MSC: i NCLEX: iSafe iand iEffective iCare iEnvironment: iManagement iof iCare
2. The ipatient iis ito ireceive ioral iguaifenesin i(Mucinex) itwice ia iday. iToday, ithe inurse iwas ibusy
andigave ithe imedication i2 ihours iafter ithe ischeduled idose iwas idue. iWhat itype iof iproblem
i
does ithis irepresent?
i
a. ―Right itime‖
b. ―Right idose‖
c. ―Right iroute‖
d. ―Right imedication‖
ANS: i A
―Right itime‖ iis icorrect ibecause ithe imedication iwas igiven imore ithan i30 iminutes iafter ithe
ischeduled idose iwas idue. i ―Dose‖ iis iincorrect ibecause ithe idose iis inot irelated ito ithe itime ithe
imedication iadministration i is i scheduled. i ―Route‖ iis iincorrect ibecause ithe iroute iis inot iaffected.
―Medication‖ iis iincorrect ibecause ithe imedication iordered iwill inot ichange.
DIF: COGNITIVE iLEVEL: iApplying i(Application)
iTOP: i NURSING iPROCESS: i Implementation
MSC: i NCLEX: iSafe iand iEffective iCare iEnvironment: iSafety iand iInfection iControl
3. The inurse ihas ibeen imonitoring ithe ipatient‘s iprogress ion ia inew idrug iregimen isince ithe ifirst
idoseiand idocumenting ithe ipatient‘s itherapeutic iresponse ito ithe imedication. iWhich iphase iof
ithe inursing iprocess ido ithese iactions iillustrate?
a. Nursing idiagnosis
,Contents
Chapter i01: iThe iNursing iProcess iand iDrug iTherapy ............................................................................... 4
Chapter i02: iPharmacologic iPrinciples ..................................................................................................... 8
Chapter i03: iLifespan iConsiderations ..................................................................................................... 14
Chapter i04: iCultural, iLegal, iand iEthical iConsiderations ........................................................................ 20
Chapter i05: iMedication iErrors: iPreventing iand iResponding ................................................................. 26
Chapter i06: iPatient iEducation iand iDrug iTherapy.................................................................................. 29
Chapter i07: iOver-the-Counter iDrugs iand iHerbal iand iDietary iSupplements.......................................... 34
Chapter i08: iGene iTherapy iand iPharmacogenomics .............................................................................. 38
Chapter i09: iPhoto iAtlas iof iDrug iAdministration ................................................................................... 41
Chapter i10: iAnalgesic iDrugs.................................................................................................................. 50
Chapter i11: iGeneral iand iLocal iAnesthetics........................................................................................... 57
Chapter i12: iCentral iNervous iSystem iDepressants iand iMuscle iRelaxants.............................................. 61
Chapter i13: iCentral iNervous iSystem iStimulants iand iRelated iDrugs..................................................... 66
Chapter i14: iAntiepileptic iDrugs ............................................................................................................ 70
Chapter i15: iAntiparkinson iDrugs........................................................................................................... 76
Chapter i16: iPsychotherapeutic iDrugs ................................................................................................... 81
Chapter i17: iSubstance iUse iDisorder ..................................................................................................... 88
Chapter i18: iAdrenergic iDrugs ............................................................................................................... 93
Chapter i19: iAdrenergic-Blocking iDrugs ................................................................................................. 98
Chapter i20: iCholinergic iDrugs............................................................................................................. 103
Chapter i21: iCholinergic-Blocking iDrugs............................................................................................... 108
Chapter i22: iAntihypertensive iDrugs.................................................................................................... 113
Chapter i23: iAntianginal iDrugs ............................................................................................................ 119
Chapter i24: iHeart iFailure iDrugs .......................................................................................................... 125
Chapter i25: iAntidysrhythmic iDrugs .................................................................................................... 131
Chapter i26: iCoagulation iModifier iDrugs ............................................................................................. 137
Chapter i27: iAntilipemic iDrugs............................................................................................................. 143
Chapter i28: iDiuretic iDrugs .................................................................................................................. 148
Chapter i29: iFluids iand iElectrolytes ..................................................................................................... 154
Chapter i30: iPituitary iDrugs ................................................................................................................. 160
,Chapter i31: iThyroid iand iAntithyroid iDrugs......................................................................................... 163
Chapter i32: iAntidiabetic iDrugs ........................................................................................................... 168
Chapter i33: iAdrenal iDrugs .................................................................................................................. 177
Chapter i34: iWomen’s iHealth iDrugs .................................................................................................... 181
Chapter i35: iMen’s iHealth iDrugs ......................................................................................................... 188
Chapter i36: iAntihistamines, iDecongestants, iAntitussives, iand iExpectorants ...................................... 193
Chapter i37: iRespiratory iDrugs ............................................................................................................ 198
Chapter i38: iAntibiotics iPart i1 ............................................................................................................. 204
Chapter i39: iAntibiotics iPart i2 ............................................................................................................. 211
Chapter i40: iAntiviral iDrugs ................................................................................................................. 216
Chapter i41: iAntitubercular iDrugs ........................................................................................................ 221
Chapter i42: iAntifungal iDrugs .............................................................................................................. 226
Chapter i43: iAntimalarial, iAntiprotozoal, iand iAnthelmintic iDrugs ....................................................... 231
Chapter i44: iAnti-inflammatory iand iAntigout iDrugs ............................................................................ 236
Chapter i45: iAntineoplastic iDrugs iPart i1: iCancer iOverview iand iCell iCycle–Specific iDrugs .................. 242
Chapter i46: iAntineoplastic iDrugs iPart i2: iCell iCycle–Nonspecific iDrugs iand iMiscellaneous iDrugs....... 248
Chapter i47: iBiologic iResponse–Modifying iand iAntirheumatic iDrugs .................................................. 253
Chapter i48: iImmunosuppressant iDrugs .............................................................................................. 258
Chapter i49: iImmunizing iDrugs ............................................................................................................ 263
Chapter i50: iAcid-Controlling iDrugs ..................................................................................................... 268
Chapter i51: iBowel iDisorder iDrugs ...................................................................................................... 274
Chapter i52: iAntiemetic iand iAntinausea iDrugs ................................................................................... 281
Chapter i53: iVitamins iand iMinerals ..................................................................................................... 286
Chapter i54: iAnemia iDrugs .................................................................................................................. 292
Chapter i55: iNutritional iSupplements .................................................................................................. 299
Chapter i56: iDermatologic iDrugs ......................................................................................................... 304
Chapter i57: iOphthalmic iDrugs ............................................................................................................ 310
Chapter i58: iOtic iDrugs ........................................................................................................................ 315
, Chapter i01: iThe iNursing iProcess iand iDrug iTherapy i i i i i 4
Chapter 01: The Nursing Process and Drug Therapy
i i i i i i i
MULTIPLE iCHOICE
1. The inurse iis iwriting ia inursing idiagnosis ifor ia iplan iof icare ifor ia ipatient iwho ihas ibeen
newlyidiagnosed iwith itype i2 idiabetes. iWhich istatement ireflects ithe icorrect iformat ifor ia
i
nursing idiagnosis?
i
a. Anxiety
b. Anxiety irelated ito inew idrug itherapy
c. Anxiety irelated ito ianxious ifeelings iabout idrug itherapy, ias ievidenced iby
istatementsisuch ias i―I‘m iupset iabout i having ito itest imy iblood i sugars.‖
d. Anxiety irelated ito inew idrug itherapy, ias ievidenced iby istatements isuch ias
i ―I‘m iupset iabout ihaving ito itest i my iblood i sugars.‖
ANS: i D
Formulation iof inursing idiagnoses iis iusually ia ithree-step iprocess. i―Anxiety‖ iis imissing ithe
―related ito‖ iand i―as ievidenced iby‖ iportions iof idefining icharacteristics. i―Anxiety irelated ito
inew idrug itherapy‖ iis imissing ithe i―as ievidenced iby‖ iportion iof idefining icharacteristics. iThe
istatementibeginning i―Anxiety irelated ito ianxious ifeelings‖ iis iincorrect ibecause ithe i ―related ito‖
isection iis i simply ia irestatement iof ithe iproblem i ―anxiety,‖ inot ia iseparate ifactor irelated ito ithe
iresponse.
DIF: COGNITIVE iLEVEL: iUnderstanding
i(Comprehension)iTOP: i NURSING iPROCESS: iNursing
iDiagnosis
MSC: i NCLEX: iSafe iand iEffective iCare iEnvironment: iManagement iof iCare
2. The ipatient iis ito ireceive ioral iguaifenesin i(Mucinex) itwice ia iday. iToday, ithe inurse iwas ibusy
andigave ithe imedication i2 ihours iafter ithe ischeduled idose iwas idue. iWhat itype iof iproblem
i
does ithis irepresent?
i
a. ―Right itime‖
b. ―Right idose‖
c. ―Right iroute‖
d. ―Right imedication‖
ANS: i A
―Right itime‖ iis icorrect ibecause ithe imedication iwas igiven imore ithan i30 iminutes iafter ithe
ischeduled idose iwas idue. i ―Dose‖ iis iincorrect ibecause ithe idose iis inot irelated ito ithe itime ithe
imedication iadministration i is i scheduled. i ―Route‖ iis iincorrect ibecause ithe iroute iis inot iaffected.
―Medication‖ iis iincorrect ibecause ithe imedication iordered iwill inot ichange.
DIF: COGNITIVE iLEVEL: iApplying i(Application)
iTOP: i NURSING iPROCESS: i Implementation
MSC: i NCLEX: iSafe iand iEffective iCare iEnvironment: iSafety iand iInfection iControl
3. The inurse ihas ibeen imonitoring ithe ipatient‘s iprogress ion ia inew idrug iregimen isince ithe ifirst
idoseiand idocumenting ithe ipatient‘s itherapeutic iresponse ito ithe imedication. iWhich iphase iof
ithe inursing iprocess ido ithese iactions iillustrate?
a. Nursing idiagnosis
